Cerus Corp. logo

CERS

Cerus Corp.

$4.8

Earnings Summary

Revenue
$43.02Mn
Net Profits
$-12.28Mn
Net Profit Margins
-28.55%

Highlights

Revenue:

Cerus Corp.’s revenue jumped 45.5% since last year same period to $43.02Mn in the Q1 2022. On a quarterly growth basis, Cerus Corp. has generated -14.11% fall in its revenue since last 3-months.

Net Profits:

Cerus Corp.’s net profit jumped 29.63% since last year same period to $-12.28Mn in the Q1 2022. On a quarterly growth basis, Cerus Corp. has generated -34.71% fall in its net profits since last 3-months.

Net Profit Margins:

Cerus Corp.’s net profit margin jumped 51.64% since last year same period to -28.55% in the Q1 2022. On a quarterly growth basis, Cerus Corp. has generated -56.84% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Cerus Corp. post its latest quarter earnings

EPS Estimate Current Quarter
-0.07
EPS Estimate Current Year
-0.07

Highlights

EPS Estimate Current Quarter:

Cerus Corp.’s earning per share (EPS) estimates for the current quarter stand at -0.07 - a 22.22% jump from last quarter’s estimates.

EPS Estimate Current Year:

Cerus Corp.’s earning per share (EPS) estimates for the current year stand at -0.07.

Key Ratios

Key ratios of the Cerus Corp. post its Q1 2022 earnings

Earning Per Share (EPS)
-0.07
Return on Assets (ROA)
-0.1
Return on Equity (ROE)
-0.52
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Cerus Corp.’s earning per share (EPS) jumped 30% since last year same period to -0.07 in the Q1 2022. This indicates that the Cerus Corp. has generated 30% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Cerus Corp.’s return on assets (ROA) stands at -0.1.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Cerus Corp.’s return on equity (ROE) stands at -0.52.

Dividend Per Share (DPS):

Cerus Corp. declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-05
-0.09
-0.07
22.22%

Company Information

Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency.

Organisation
Cerus Corp.
Headquarters
Concord, California, US
Employees
266
Industry
Health Technology
CEO
William Greenman